Plimoth Trust’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$306K Buy
4,259
+94
+2% +$7.24K 0.07% 146
2025
Q4
$331K Sell
4,165
-275
-6% -$21.7K 0.07% 147
2025
Q3
$335K Sell
4,440
-565
-11% -$38.7K 0.08% 143
2025
Q2
$345K Sell
5,005
-55
-1% -$3.61K 0.08% 145
2025
Q1
$343K Sell
5,060
-24,901
-83% -$1.49M 0.09% 144
2024
Q4
$1.34M Sell
29,961
-9,646
-24% -$541K 0.35% 74
2024
Q3
$2.49M Sell
39,607
-7,030
-15% -$410K 0.63% 52
2024
Q2
$2.75M Buy
46,637
+174
+0.4% +$10.9K 0.73% 43
2024
Q1
$3.71M Buy
46,463
+935
+2% +$71.4K 0.99% 37
2023
Q4
$3.59M Sell
45,528
-13
-0% -$925 1.04% 31
2023
Q3
$3.18M Buy
45,541
+4,730
+12% +$335K 1% 32
2023
Q2
$2.82M Buy
40,811
+3,215
+9% +$229K 0.84% 41
2023
Q1
$2.79M Buy
37,596
+1,926
+5% +$162K 0.87% 38
2022
Q4
$3.32M Sell
35,670
-551
-2% -$53.2K 1.07% 28
2022
Q3
$3.46M Buy
36,221
+1,329
+4% +$132K 1.19% 21
2022
Q2
$3.23M Sell
34,892
-546
-2% -$53.3K 1.02% 27
2022
Q1
$3.59M Sell
35,438
-2,516
-7% -$264K 0.95% 31
2021
Q4
$3.92M Sell
37,954
-333
-0.9% -$30.8K 0.99% 30
2021
Q3
$3.25M Sell
38,287
-78
-0.2% -$6.53K 0.92% 32
2021
Q2
$3.2M Sell
38,365
-548
-1% -$44.9K 0.9% 33
2021
Q1
$2.93M Buy
38,913
+458
+1% +$33.4K 0.86% 38
2020
Q4
$2.63M Buy
38,455
+815
+2% +$53K 0.82% 44
2020
Q3
$2.2M Buy
37,640
+1,205
+3% +$75K 0.74% 45
2020
Q2
$2.37M Buy
36,435
+1,497
+4% +$94.3K 0.84% 39
2020
Q1
$2.07M Sell
34,938
-164
-0.5% -$10.9K 0.87% 35
2019
Q4
$2.61M Sell
35,102
-853
-2% -$59.9K 0.84% 34
2019
Q3
$2.27M Buy
35,955
+326
+0.9% +$19.3K 0.74% 37
2019
Q2
$1.94M Buy
35,629
+1,545
+5% +$83.2K 0.64% 50
2019
Q1
$1.84M Buy
34,084
+2,486
+8% +$153K 0.61% 56
2018
Q4
$2.07M Sell
31,598
-574
-2% -$42.8K 0.76% 41
2018
Q3
$2.53M Buy
32,172
+720
+2% +$51.5K 0.82% 36
2018
Q2
$2.02M Buy
31,452
+3,422
+12% +$226K 0.69% 48
2018
Q1
$1.74M Buy
28,030
+618
+2% +$44.3K 0.6% 56
2017
Q4
$1.99M Buy
+27,412
New +$1.99M 0.71% 45

Other funds holding CVS

Plimoth Trust's CVS Position: Q1 2026 in Review

Plimoth Trust increased its CVS Health (CVS) stake by 2.3% in Q1 2026, buying an estimated $7.24K and bringing the position to 4,259 shares worth $306K. The position accounts for 0.07% of the portfolio, ranked #146.

Plimoth Trust first reported a position in CVS in Q4 2017 and has held it in 34 quarters since. The position peaked at $3.92M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Plimoth Trust held 4,259 shares of CVS Health worth $306K as of Q1 2026.
  • Plimoth Trust bought 94 CVS Health shares in Q1 2026, an estimated $7.24K.
  • CVS Health made up 0.07% of Plimoth Trust's portfolio in Q1 2026, its #146 holding.
  • Plimoth Trust first reported a position in CVS Health in Q4 2017 and has held it in 34 quarters since.
  • Plimoth Trust's CVS Health position peaked at $3.92M in Q4 2021.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Plimoth Trust's 13F filing for Q1 2026, filed 27 Apr 2026.